Science and technology

MiraxBioPharma develops innovative medicinal products, dietary supplements, and cosmetics based on compounds of natural and synthetic origin, using advanced scientific achievements and high-tech equipment.

Scientific division

Our scientific division provides comprehensive, full-scale support for each product throughout its entire life cycle — from the initial idea and development of the active substance to the product’s introduction into medical practice.

We carry out technological development at our own state-of-the-art innovation facility

Leading scientific institutions in Russia, including Pirogov Russian National Research Medical University (RNRMU), RUDN University, and the Institute of Human Ecology and Environmental Hygiene (IHEEH), participate in our unique pilot studies

Our preclinical and clinical studies are conducted at more than 50 medical institutions across the country

We actively engage both the medical community and the broader public with modern approaches to the prevention and treatment of various diseases through monographs, articles in Russian and international scientific and popular science journals, and public presentations. The results of our research and development are published in periodicals indexed in global scientific article databases. All of this enables us to contribute to the advancement of medical science and practice, as well as to ensure the safe and effective use of our products.

Patents

Certificate of Compliance of the Manufacturer of Medicinal Products for Medical Use with the Requirements of Good Manufacturing Practice

Research articles

  • Preclinical antitumor activity of the diindolylmethane formulation in xenograft mouse model of prostate cancer
    Read more
  • Safety and tolerability of DIM-based therapy designed as personalized approach to reverse prostatic intraepithelial neoplasia (PIN)
    Read more
  • Comparative preclinical pharmacokinetics study of 3,3?-diindolylmethane formulations: is personalized treatment and targeted chemoprevention in the horizon?
    Read more

Contact us

Select a service*

Pharmacovigilance

MiraxBioPharma is committed to ensuring the quality and safety of its products and pays special attention to collecting and analyzing information about adverse reactions and complaints associated with the use of our products.

If you become aware of any adverse reactions to the medicinal product Cezarox® Epi or of a lack of therapeutic effect, please report it via email at: adversareaction@drugsafety.ru or by phone: +7 (800) 777-86-04.

If you become aware of any adverse reactions to other MiraxBioPharma medicinal products or of a lack of therapeutic effect, please report it via email at: GVP@mbpharma.ru, by phone: +7 (495) 183-38-41 or by filling out the electronic form below

Adverse reaction reporting form
Specify gender*
Suspected medicinal product information
Reporter information

Preferred method of contact*
We use cookies

By using this website, you consent to the collection and processing of your personal data, including through third-party services, and the use of cookies and web analytics tools, under the terms outlined in the Personal Data Processing Policy.